Direkt zum Inhalt

Aus der ZeitschriftLSR 4/2021 | S. 257–263Es folgt Seite №257

Medical Cannabis in Switzerland

A Paradigm Shift in Swiss Regulations

Keywords:
Cannabis, New Regulation

Abstract

The decision of the Swiss Parliament to declare cannabis containing THC as a marketable substance with regard to the medical use represents a turning point in Swiss cannabis regulation. Before, cannabis narcotics have been subject to a traffic ban. The liberalisation aims in particular to facilitate the research and development of medicinal products based on…
[…]